Cleared Traditional

K131064 - BIOSPACE

K131064 is an FDA 510(k) clearance for BIOSPACE, manufactured by Biospace Corporation Limited. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 141-day FDA review.

K131064 · Biospace Corporation Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2013
Decision
141d
Days
Class 2
Risk

K131064 is an FDA 510(k) clearance for the BIOSPACE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Biospace Corporation Limited (Naples, US). The FDA issued a Cleared decision on September 4, 2013 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biospace Corporation Limited devices

FDA 510(k) Submission Details - K131064

510(k) Number K131064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 2013
Decision Date September 04, 2013
Days to Decision 141 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 125d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K131064.
ANSWATCH WRIST MONITOR MODEL TS-0411
K123130 · Taiwan Scientific Corporation · Sep 2013
ELECTRONIC BLOOD PRESSURE MONITOR FOR UPPER ARM
K130232 · Jinxinbao Electronic Co.,Ltd · Sep 2013
AUTOMATIC BLOOD PRESSURE MONITOR
K130925 · Honsun (Nantong) Co., Ltd. · Sep 2013
PG-800B SERIES, INCLUDING PG-800BD, PG-800B-1, PG-800BD-1, PG-800B3, PG-800B4, PG-800B4D, PG-800B5, PG-800B5-1, PG-800B6
K131558 · Shenzhen Pango Electronic Co., Ltd. · Aug 2013
AGE AUTOMATIC UPPER ARM BLOOD PRESSURE MONITOR
K123882 · Ageless Health Industrial · Aug 2013
HEM-6131
K131742 · Omron Healthcare, Inc. · Jul 2013